Zydus Wellness Limited (IN:ZYDUSWELL)
:ZYDUSWELL
Top Page
Zydus Wellness Limited
(ZYDUSWELL)
Select Model
Select Model
Rating:66Neutral
Price Target:
₹528.00
▲(24.26% Upside)
Action:DowngradedDate:12/18/25
Zydus Wellness Limited's overall stock score is primarily driven by its strong financial performance, characterized by consistent revenue growth and a robust balance sheet. However, the technical analysis indicates bearish momentum, and the high P/E ratio suggests potential overvaluation, which tempers the overall score.
Positive Factors
Consistent revenue growth
Sustained top-line growth indicates broad-based demand and effective brand penetration across channels. Over a 2-6 month horizon this underpins scale advantages in distribution and marketing, supporting reinvestment capacity and resilience against single-channel volatility.
Negative Factors
Declining EPS
A sharp decline in EPS signals pressure on per-share profitability that can persist if structural cost or mix issues remain. Over months this can constrain retained earnings growth, limit dividend flexibility, and reduce internal funding available for brand and distribution expansion.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent revenue growth
Sustained top-line growth indicates broad-based demand and effective brand penetration across channels. Over a 2-6 month horizon this underpins scale advantages in distribution and marketing, supporting reinvestment capacity and resilience against single-channel volatility.
Read all positive factors
Zydus Wellness Limited (ZYDUSWELL) vs. iShares MSCI India ETF (INDA)
Market Cap
₹155.90B
Dividend Yield0.28%
Average Volume (3M)15.16K
Price to Earnings (P/E)―
Beta (1Y)0.70
Revenue Growth14.55%
EPS Growth-20.61%
CountryIN
Employees1,008
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)-1.30
Shares Outstanding318,160,700
10 Day Avg. Volume9,092
30 Day Avg. Volume15,161
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)0.38
Price to Sales (P/S)0.79
P/FCF Ratio6.81
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)13.24
Revenue Forecast (FY)₹52.58B
Zydus Wellness Limited Business Overview & Revenue Model
Company Description
Zydus Wellness Limited develops, produces, markets, and distributes health and wellness products in India. It provides sugar substitute products under the Sugar Free Gold, Sugar Free Natura, and Sugar Free Green brands; milk-based health food drin...
How the Company Makes Money
Zydus Wellness primarily makes money by manufacturing, marketing, and selling branded consumer wellness products to retailers, distributors, and e-commerce channels, generating revenue from the sale of packaged goods at scale. Its core revenue mod...
Zydus Wellness Limited Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
82
Very Positive
Cash Flow
75
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.73B | 27.09B | 23.28B | 22.55B | 20.09B | 18.67B |
| Gross Profit | 13.52B | 10.77B | 8.87B | 10.96B | 7.41B | 10.08B |
| EBITDA | 3.58B | 3.99B | 3.08B | 3.32B | 3.55B | 2.21B |
| Net Income | 2.53B | 3.47B | 2.67B | 3.10B | 3.09B | 1.19B |
Balance Sheet | ||||||
| Total Assets | 98.81B | 64.42B | 61.48B | 58.33B | 56.92B | 56.66B |
| Cash, Cash Equivalents and Short-Term Investments | 1.48B | 1.29B | 3.16B | 1.08B | 1.96B | 2.52B |
| Total Debt | 30.42B | 1.88B | 3.29B | 2.97B | 3.87B | 5.50B |
| Total Liabilities | 41.76B | 7.70B | 7.91B | 7.11B | 8.48B | 10.99B |
| Stockholders Equity | 57.06B | 56.72B | 53.58B | 51.23B | 48.44B | 45.68B |
Cash Flow | ||||||
| Free Cash Flow | 235.00M | 3.14B | 2.18B | 467.00M | 1.61B | 2.67B |
| Operating Cash Flow | 931.00M | 3.80B | 2.46B | 917.00M | 2.37B | 2.87B |
| Investing Cash Flow | -28.68B | -2.24B | -1.78B | -849.00M | -859.50M | -104.10M |
| Financing Cash Flow | 28.01B | -1.86B | -257.00M | -1.39B | -2.34B | -2.16B |
Zydus Wellness Limited Technical Analysis
Positive
424.90
Price Trends
417.61
Positive
427.54
Positive
433.73
Positive
Market Momentum
22.50
Negative
64.29
Neutral
63.04
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ZYDUSWELL, the sentiment is Positive. The current price of 424.9 is below the 20-day moving average (MA) of 441.35, above the 50-day MA of 417.61, and below the 200-day MA of 433.73, indicating a bullish trend. The MACD of 22.50 indicates Negative momentum. The RSI at 64.29 is Neutral, neither overbought nor oversold. The STOCH value of 63.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:ZYDUSWELL.
Zydus Wellness Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ₹140.60B | 42.68 | ― | 0.26% | 5.73% | -7.74% | |
66 Neutral | ₹155.90B | -90.62 | ― | 0.28% | 14.55% | -20.61% | |
66 Neutral | ₹70.05B | 34.81 | ― | 0.77% | 24.93% | 20.57% | |
64 Neutral | ₹160.77B | 75.55 | ― | 0.13% | 11.04% | -26.83% | |
64 Neutral | ₹81.37B | 31.99 | ― | 1.24% | 1.62% | -7.32% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ₹57.88B | 46.45 | ― | 0.45% | 10.82% | -8.21% |
* Consumer Defensive Sector Average
IN:ZYDUSWELL
Zydus Wellness Limited
488.85
140.17
40.20%
IN:BECTORFOOD
Mrs. Bector's Food Specialities Ltd.
193.05
-122.43
-38.81%
IN:BIKAJI
Bikaji Foods International Ltd.
640.05
-68.31
-9.64%
IN:FINEORG
Fine Organic Industries Ltd.
4,638.50
605.02
15.00%
IN:JYOTHYLAB
Jyothy Labs Limited
225.45
-137.84
-37.94%
IN:PGIL
Pearl Global Industries Limited
1,537.20
534.01
53.23%
Zydus Wellness Limited Corporate Events
Zydus Wellness Says Surge in Share Volume Is Market Driven, No Undisclosed Events
Apr 7, 2026
Zydus Wellness Limited has responded to a query from the National Stock Exchange of India regarding a recent significant increase in trading volumes of its equity shares. The company stated that it has complied with all disclosure requirements und...
Zydus Wellness Subsidiary to Appeal Spanish VAT Penalty
Apr 4, 2026
Zydus Wellness Limited disclosed that its step-down wholly owned subsidiary, Comfort Click Limited in the U.K., has received an order from the Spanish Tax Authority alleging unpaid value added tax for the first quarter of 2021. The authority has i...
Zydus Wellness Shares Revised Investor Presentation Ahead of March Conference
Mar 18, 2026
Zydus Wellness Limited has released a revised investor presentation ahead of its Analyst and Institutional Investors’ Conference scheduled for March 18 and 19, 2026. The updated deck has been shared with stock exchanges and uploaded on the c...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.